Search for: "Endo Pharmaceuticals Inc."
Results 121 - 140
of 154
Sorted by Relevance
|
Sort by Date
1 Jan 2016, 9:00 am
Apotex Inc., No. 15-281 Mylan Pharmaceuticals Inc. v. [read post]
14 Nov 2016, 9:16 am
Teva Pharmaceuticals USA, Inc., et al. [read post]
6 Jul 2011, 2:21 am
Biopet Vet Lab, Inc., et. al. [read post]
2 Jun 2011, 12:46 pm
Ortho Pharmaceutical Corp., 681 P.2d 1038, 1052 (Kan. 1984). [read post]
13 Oct 2016, 6:50 am
Teva Pharmaceuticals USA, Inc., et al. [read post]
8 May 2008, 12:22 pm
Wyeth Pharmaceuticals, 2008 WL 1821379 (5th Cir. [read post]
4 Mar 2016, 12:25 pm
Apotex Inc., No. 15-281 Mylan Pharmaceuticals Inc. v. [read post]
3 Mar 2010, 5:05 am
(IP Osgoode) Australia: University of Western Australia’s application to appeal FCAFC’s decision in University of Western Australia v Gray fails (IP Whiteboard) Colombia/EU/Peru: Tough IP health provisions in Europe’s Colombia/Peru trade deal (IP Watch) (IP tango) EU: Something more about Swiss type claims: G02/08 (SiNApSE) (SiNApSE) US: Pharmaceutical patent settlements – and what about patients? [read post]
3 Mar 2010, 5:05 am
(IP Osgoode) Australia: University of Western Australia’s application to appeal FCAFC’s decision in University of Western Australia v Gray fails (IP Whiteboard) Colombia/EU/Peru: Tough IP health provisions in Europe’s Colombia/Peru trade deal (IP Watch) (IP tango) EU: Something more about Swiss type claims: G02/08 (SiNApSE) (SiNApSE) US: Pharmaceutical patent settlements – and what about patients? [read post]
15 Jul 2009, 5:15 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: European Commission Competition DG releases final report on pharmaceutical sector (IPKat) (PatLit) (BLOG@IP::JUR) (IAM) (Managing Intellectual Property) (Intellectual Property Watch) (The SPC Blog) (IAM) US: Follow-on biologics proposals considered by US Senate HELP Committee; Committee passes amendment for 12-year biologics exclusivity period… [read post]
17 Feb 2016, 9:20 am
Apotex Inc., No. 15-281 Mylan Pharmaceuticals Inc. v. [read post]
3 Feb 2016, 8:57 am
Apotex Inc., No. 15-281 Mylan Pharmaceuticals Inc. v. [read post]
18 May 2016, 8:19 am
Lexmark International, Inc., No. 15-1189 (unreasonable restraints on downstream uses) Obviousness: Cubist Pharmaceuticals, Inc. v. [read post]
18 Apr 2016, 9:58 am
Lexmark International, Inc., No. 15-1189 (unreasonable restraints on downstream uses) Obviousness: Cubist Pharmaceuticals, Inc. v. [read post]
1 Apr 2016, 8:22 am
Lexmark International, Inc., No. 15-1189 (unreasonable restraints on downstream uses) Obviousness: Cubist Pharmaceuticals, Inc. v. [read post]
3 May 2016, 1:42 am
Lexmark International, Inc., No. 15-1189 (unreasonable restraints on downstream uses) Obviousness: Cubist Pharmaceuticals, Inc. v. [read post]
28 Jun 2016, 6:41 am
Momenta Pharmaceuticals, Inc., et al., No. 15-1402 (scope of 271(e) safe harbor) Exhaustion: Impression Products, Inc. v. [read post]
4 May 2011, 7:52 am
Generic Opioid Products Generic Name Drug Name Applicant/Sponsors Fentanyl Fentanyl Extended Release Transdermal System Actavis Fentanyl Fentanyl Extended Release Transdermal System Lavipharm Labs Fentanyl Fentanyl Extended Release Transdermal System Mylan Technologies Fentanyl Fentanyl Extended Release Transdermal System Teva Pharms Fentanyl Fentanyl Extended Release Transdermal System Watson Methadone … [read post]
17 Mar 2016, 2:45 am
Ethicon Endo-Surgery, Inc., No. 15-115 Nautilus, Inc. v. [read post]
7 Apr 2010, 4:30 am
Sandoz Pharmaceuticals GmbH et al (EPLAW) Prilosec (Omeprazole) – US: AstraZeneca ordered to pay attorney’s fees for ‘baseless’ suit to protect Prilosec OTC: AstraZeneca AB et al. v. [read post]
